An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported researchers.
from Latest Science News -- ScienceDaily http://bit.ly/2ItmAyv
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment